MedTrace Logo

RCT to Evaluate the Cosmetic Efficacy of Demo-cosmetic Active Ingredient CLS02021

NCT05048121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-09-24

No results posted yet for this study

Summary

This study will explore the potential of probiotic based, novel cosmetic active ingredient to rebuild the collagen based skin barrier with the overall aim to rejuvenate ageing or damaged skin, improve skin integrity, appearance, beauty, and support personal well-being and vitality.

Conditions

  • Overall Skin Appearance
  • Dry Skin; Eczema

Interventions

OTHER

Cosmetic Active Ingredient CLS02021

Topical, face application of the cream base with the CLS02021, two times a day in a period of 30 days

OTHER

Placebo PLC01021

Topical, face application of the cream base, two times a day in a period of 30 days

Sponsors & Collaborators

  • Sarajevo School of Science and Technology, Medical School Department

    collaborator UNKNOWN

  • Public Institution Sarajevo Pharmacies

    collaborator UNKNOWN

  • Anbiome Labs LLC

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-24
Primary Completion
2021-09-15
Completion
2021-09-23

Countries

  • Bosnia and Herzegovina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05048121 on ClinicalTrials.gov